Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001683168-21-001801
Filing Date
2021-05-06
Accepted
2021-05-06 17:00:16
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A phio_defa14a.htm DEFA14A 17102
2 GRAPHIC image1.jpg GRAPHIC 137961
3 GRAPHIC image2.jpg GRAPHIC 100160
  Complete submission text file 0001683168-21-001801.txt   346430
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36304 | Film No.: 21898749
SIC: 2834 Pharmaceutical Preparations